Myriad Genetics receives US FDA approval for MyChoice CDx test as companion diagnostic for Zejula for patients with ovarian cancer: Salt Lake City Thursday, March 19, 2026, 15:00 ...

Approval reinforces Myriad’s leadership in comprehensive HRD testing and establishes MyChoice CDx as the only FDA-approved ...

Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, today announced that the U.S. Food and Drug ...

Last year, EastEnders legend Kara Tointon underwent a double mastectomy and had her fallopian tubes removed after discovering ...

Starting a family is one of the most personal journeys a couple can take. When that journey feels more difficult than expected, it is completely natural to ...

An ovarian cancer survivor reflects on community, advocacy, and living a life shaped by purpose—not just diagnosis.

Dr. Eichenbaum commented, “Femasys is advancing innovative, non-surgical solutions designed to improve the patient experience while reducing cost and complexity in women’s reproductive care. I look ...

Whether you're just starting to think about having kids, or trying to conceive right now, here are the golden rules (backed ...

Jessica Hill has suffered from endometriosis symptoms from the age of 14 A clinical trial aims to help women receive an ...

Pembrolizumab plus weekly paclitaxel, with investigator-choice bevacizumab, achieved statistically significant PFS and OS improvements, addressing a high unmet need in platinum-resistant ovarian ...

Bay Area laboratory solutions company Agilent Technologies has agreed to acquire Biocare Medical, a pathology solutions business, in an all-cash transaction valued at $950 million. | Bay Area ...

Progesterone, which is produced in the ovaries after ovulation and is responsible for regulating your menstrual cycle, is ...